NewEdge Advisors’s Vivani Medical VANI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,333
Closed -$1.56K 4029
2024
Q3
$1.56K Sell
1,333
-66
-5% -$83 ﹤0.01% 3435
2024
Q2
$1.76K Buy
1,399
+66
+5% +$113 ﹤0.01% 3362
2024
Q1
$2.47K Buy
1,333
+1,000
+300% +$1.47K ﹤0.01% 3327
2023
Q4
$340 Hold
333
﹤0.01% 3567
2023
Q3
$340 Hold
333
﹤0.01% 3285
2023
Q2
$403 Sell
333
-166
-33% -$204 ﹤0.01% 3334
2023
Q1
$499 Hold
499
﹤0.01% 3239
2022
Q4
$0 Buy
+499
New +$813 ﹤0.01% 4216
2021
Q3
Sell
-4,059
Closed -$60K 1227
2021
Q2
$60K Buy
+4,059
New +$78.4K ﹤0.01% 1113

Other funds holding VANI

NewEdge Advisors's VANI Position: Q4 2024 in Review

NewEdge Advisors sold out of Vivani Medical (VANI) in Q4 2024, closing a stake of 1,333 shares — an estimated $1.56K sold.

NewEdge Advisors first reported a position in VANI in Q2 2021 and held it in 9 quarters. The position peaked at $60K in Q2 2021. 32 funds tracked by Wall St. Rank hold VANI as of Q4 2024.

  • NewEdge Advisors reported no remaining Vivani Medical position as of Q4 2024 after selling out during the quarter.
  • NewEdge Advisors sold 1,333 Vivani Medical shares in Q4 2024, an estimated $1.56K.
  • NewEdge Advisors first reported a position in Vivani Medical in Q2 2021 and held it in 9 quarters.
  • NewEdge Advisors's Vivani Medical position peaked at $60K in Q2 2021.
  • 32 funds tracked by Wall St. Rank held Vivani Medical as of Q4 2024.

Based on NewEdge Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.